Previous studies have shown that more advanced AD pathology and neurodegeneration, as measured by CSF Aβ, p-tau and neurofilament light (NfL) levels, respectively, are associated with greater spatial navigation deficits. The gene discussed is NEFL; the disease is Alzheimer disease.